# clm_BDCB60E4D48C

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_assets  
value: 13,939,300,000 United States dollar  
valid_from: 2019-09-30  
valid_to: 2019-12-31  
published: 2019-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_A8B1190C6433  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total assets: 13,939,300,000 United States dollar", as of 2019-09-30 (until 2019-12-31). Claim clm_BDCB60E4D48C, https://asof.is/claim/clm_BDCB60E4D48C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217619000034/0001532176-19-000034-index.htm (primary, SEC EDGAR 10-Q Q3 FY2019, published 2019-11-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_assets | 13,173,600,000 United States dollar | valid 2019-06-30 to 2019-09-30 | conf 0.95 | superseded | superseded_by [clm_BDCB60E4D48C](/claim/clm_BDCB60E4D48C.md) | [clm_1663DBFF8E0F](/claim/clm_1663DBFF8E0F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.